ZPRÁVA O PRŮBĚHU KLINICKÉHO HODNOCENÍ HALF (16.6.2021 – 15.6.2022)

Title in English REPORT ON THE PROGRESS OF THE HALF CLINICAL TRIAL (16/06/2021 – 15/06/2022)
Authors

DEMLOVÁ Regina RYCHLÍČKOVÁ Jitka

Year of publication 2022
MU Faculty or unit

Faculty of Medicine

Web HALF
Description Phase II prospective clinical study evaluating the efficacy and safety of tyrosine kinase inhibitors after previous two-stage dose reduction in patients with chronic myeloid leukemia in deep molecular remission.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info